Emglifâ„¢-MXR
Therapeutic Segment:
Anti-diabetic
Generic Name:
Empagliflozin/Metformin HCI
Description:
Emglif-MXR tablets contain two oral antihyperglycemic drugs used in the management of type 2 diabetes: empagliflozin and metformin hydrochloride.
Indication:
Emglif-MXR is a combination of empagliflozin and metformin hydrochloride indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and metformin hydrochloride is appropriate. Empagliflozin is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease.
Formulation:
- Tablets
Strength:
- 12.5mg/1000mg
- Pack Size:
- 14’s